2022 Ljubljana, Slovenia

B-07 Hans Peter Grimm
Learn-and-Confirm in Quantitative Systems Pharmacology: Evaluation of an Immunogenicity Platform
Wednesday 11:15-11:35
B-08 Rory Leisegang
Immunogenicity dynamics and covariate effects after satralizumab administration predicted with a Hidden Markov Model
Wednesday 11:55-12:15
B-08 Alix Demaris
Towards understanding anti-infliximab antibody development to predict Crohn’s disease patients' underlying immunogenicity status
Wednesday 11:35-11:55